Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication

Angiology

Volumn 59, Issue 1, 2008, Pages 84-89

  Andreozzi, Giuseppe Maria ^a   Leone, Alfredo ^b   Laudani, Rita ^b   Martin, Romeo ^a   Deinite, Gregorio ^b   Cataldi, Valentina ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Vascular Rehabilitation Unit   (Italy)

Author keywords

Intermittent claudication; Levo propionylcarnitine; Supervised physical training

Indexed keywords

PROPIONYLCARNITINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MALE; RANDOMIZED CONTROLLED TRIAL; TRAINING; WALKING;

CARNITINE; COMBINED MODALITY THERAPY; EXERCISE THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; INTERMITTENT CLAUDICATION; MALE; MUSCLE, SKELETAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 39149128229     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707304567     Document Type: Article

References (30)

1. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT Exercise training for claudication. New Engl J Med. 2002 ; 347: 1941-1951.
2. Gardner AW, Poehlman ET Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA. 1995 ; 274: 975-980.
3. Hirsch AT, Haskal ZJ, Hertzer NR ACC/AHA Guidelines for the management of PAD. J Am Coll Cardiol. 2006 ; 20 (10). 1-75.
4. Girolami B., Bernardi E., Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999 ; 159: 337-345.
5. Leng GC, Fowler B., Ernst E. Exercise for intermittent claudication (Cochrane review). In: Cochrane Library. Oxford, UK: Update Software. 2002: 3.
6. Lloyd PG, Yang HT, Terjung RL Arteriogenesis and angiogenesis in rat ischemic hindlimb; role of nitric oxide. Am J Physiol Heart Circul Physiol. 2001 ; 281: H2528 - H2538.
7. Terjung RL, Nathien GM, Erney TP, Ogilvie RW Peripheral adaptation to low blood flow in muscle during exercise. Am J Cardiol. 1988 ; 62: 15E - 19E.
8. Ernst EE, Matrai A. Intermittent claudication, exercise and blood rheology. Circulation. 1987 ; 76: 1110-1114.
9. Capecchi PL, Laghi Pasini F, Cati G., et al. Experimental model of short-time exercise-induced preconditioning in PAOD patients. Angiology. 1997 ; 48: 469-480.
10. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990 ; 81: 602-609.
11. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996 ; 81: 780-788.
12. Andreozzi GM, Signorelli S., Tornetta D. The rehabilitation in angiology. In: Strano, Novo, eds. Advances in Vascular Pathology. New York, NY: Elsevier ; 1990: 591-597.
13. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT Exercise training for claudication. New Engl J Med. 2002 ; 347: 1941-1951.
14. Angelini C., Lucke S., Cantarutti F., et al. Carnitine deficiency of skeletal muscle: report of a treated case. Neurology. 1976 ; 26: 633-637.
15. Engel AG Possible causes and effects of carnitine deficiency in man. In: Frenkel RA, Mc Garry DJ, eds. Carnitine Biosynthesis, Metabolism and Function. New York, NY: Academic Press; 1980: 271-284.
16. Hiatt WR Current and future drug therapies for claudication. Vasc Med. 1997 ; 2: 257-262.
17. Hiatt WR Carnitine and peripheral arterial disease. Ann N Y Acad Sci. 2004 ; 1033: 92-98.
18. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol. 1992 ; 73: 346-353.
19. Brevetti G., Angelini C., Rosa M., et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation. 1991 ; 84: 1490-1495.
20. Brevetti G., Perna S., Sabba C., et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol. 1995 ; 26: 1411-1416.
21. Brevetti G., Diehm C., Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol. 1999 ; 34: 1618-1624.
22. Hiatt WR, Regensteiner JG, Creager MA, et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med. 2001 ; 110: 616-622.
23. Tassani V., Cattapan F., Magnanimi L., Peschechera A. Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Biochem Biophys Res Commun. 1994 ; 199: 949-953.
24. Reznich AZ, Kagan VE, Ramsey R.,, et al. Antiradical effects in L-propionylcarnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch Biochem Biophys. 1992 ; 296: 394-402.
25. Packer L., Valenza M., Serbinova E., et al. Free radical scavenging is involved in the protective effect of L-propionylcarnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys. 1991 ; 288: 533-537.
26. Stroh R., Christopher TA, Lopez BL, et al. L-propionylcarnitine, an endogenous ester in fatty acid metablism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury. Shock. 1998 ; 9: 216-222.
27. Andreozzi GM, Martini R., Cordova R., D'Eri A. L-propionylcarnitine protects tissues from ischaemic injury in an "in vivo" human ischaemia-reperfusion model. Clin Drug Invest. 2002 ; 22 (suppl 1). 16-21.
28. Silvestro A., Schiano V., Bucur R., Brevetti G., Scopacasa F., Chiariello M. Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication. Angiology. 2006 ; 57: 145-154.
29. Andreozzi GM, Arosio E., Martini R., Verlato F., Visonà A. Consensus on intermittent claudication, Abano Terme (PD), Italy, 7 May 2005. Milano, Roma, Italy: Wolters Kluwer Health ; 2006.
30. Signorelli SS, Neri S., Di Pino L., et al. Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD. Diabetes Res Clin Pract. 2006 ; 72: 231-237.